Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250

Clinical trial NCT00602862 · COMPLETED

Trial details

NCT number: NCT00602862
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma

Start date: 2007-07-01
Primary completion: 2012-04-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.